![]() |
![]()
RECENT NEWS
Mike Numamoto joins Uptake Medical as Vice President of Marketing Seattle, Washington – (BUSINESSWIRE) – March 31, 2008 – Uptake Medical™ Corporation is pleased to announce that Mike Numamoto has joined the company as the Vice President of Marketing. He joins the company with over 20 years of experience in the life sciences and medical device industry. He served in management positions at Edwards Lifesciences, American Red Cross, VenPro Corporation, and Baxter Healthcare Corporation. "The team at Uptake Medical including the employees, supporting clinicians and Board of Directors has done a fantastic job of developing the technology and I look forward to bringing this state-of-art therapy to emphysema patients around the world", Numamoto said. "Mike's experience and knowledge in the medical device industry, along with his global marketing expertise are a perfect fit for Uptake Medical", said CEO and President King Nelson. "The addition of Mr. Numamoto provides the proven medical device global marketing and brand management leadership experience to accelerate the company through regulatory approvals and eventual commercialization of this exciting technology." noted Founder and Chief Technical Officer, Robert Barry. Mike Numamoto graduated from the Kellogg Graduate School of Management of Northwestern University with a Masters in Business Administration in Marketing and received his Bachelors of Science in Biological Sciences from the University of California-Irvine. Uptake Medical™ Corporation is a developer of medical technologies for the treatment of lung diseases including emphysema. The core technology is a simple, minimally invasive, non-implant, interventional pulmonary approach designed to measurably improve lung function and patient quality of life. Emphysema afflicts over 3 million sufferers in the U.S. Uptake Medical is a privately held company with investors that include: Prism Venture Partners, GBS Venture Partners, Onset Ventures, Affinity Capital, WRF Capital and Arboretum Ventures. < Back |
| The Bronchoscopic Thermal Vapor Ablation System (BTVA) is investigational and not approved for use in the United States or abroad. |
| ©2010 Uptake Medical™ |